Earnings Outlook For DarioHealth
Portfolio Pulse from Benzinga Insights
DarioHealth (NASDAQ:DRIO) is expected to report a quarterly EPS of $-0.54 on March 28, 2024. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for the next quarter. DarioHealth's past earnings performance shows a mixed impact on its stock price, with the last quarter's miss leading to a 32.18% increase in share price. Shares are currently trading at $1.515, down 62.14% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders.
March 27, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
DarioHealth is anticipated to report a quarterly EPS of $-0.54 on March 28, 2024. The focus will be on beating this estimate and the future guidance provided. Despite a mixed past performance, the last earnings miss resulted in a significant stock price increase. Currently, the stock is down 62.14% over the last 52 weeks, reflecting a bearish long-term sentiment.
The anticipation around DarioHealth's earnings report is high, given its history of mixed impacts on stock price following earnings announcements. The expected EPS of $-0.54 sets a clear benchmark for performance. While past performance, such as the 32.18% increase in share price after the last earnings miss, suggests potential for positive short-term movement, the overall 62.14% decline over the past year indicates a bearish long-term sentiment. The short-term impact is assessed as neutral due to the unpredictable nature of market reactions to earnings reports and guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100